Author/Authors :
Amani، Mohammad نويسنده Department of Physiology and Pharmacology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran , , Jeddi، Sajad نويسنده Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran , , Ahmadiasl، Nasser نويسنده Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. , , Usefzade، Nasibe نويسنده Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran , , Zaman، Jalal نويسنده Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran ,
Abstract :
Introduction: Ischemia/Reperfusion (IR) injury mainly causes the increase of enzymes
involved in myocytes injury including CK-MB (creatine kinase-MB) isoenzyme and LDH
(lactate dehydrogenase). Leakage of CK-MB isoenzyme and LDH from myocardial tissues
to blood is indicator of acute myocardial infarction. The aim of this study was to assess the
effect of HEMADO on IR injury and its relationship with mitochondrial ATP-sensitive K+
channels (mitoKATP) in rat heart. Methods: Twenty eight male Wistar rats (250-300g)
were divided into four groups (seven members in each group): control (without ischemia),
I/R (with ischemia+without HEMADO), ischemia received HEMADO (HEMADO),
ischemia received HEMADO and 5-HD (5-hydroxydecanoate, specific mitoKATP channel
blocker) (HEMADO+5-HD). The animals were anesthetized and the hearts were quickly
removed and mounted on Langendorff apparatus and perfused by Krebs-Henseleit solution
under constant pressure and temperature of 37?C. After 20 minutes of stabilization,
ischemic groups were exposed to 40 minutes of global ischemia and consecutive 90
minutes of reperfusion. Results: IR injury increased the level of LDH and CK-MB in the
collected coronary flow during 5 minutes since start of reperfusion. HEMADO reduced the
enzymes’ levels and using 5-HD abolished the effect of HEMADO. Conclusion: Our
findings indicated that HEMADO could protect the heart against ischemia-reperfusion
injury by decreasing the CK-MB and LDH levels. The cardioprotective effect of
HEMADO may be mediated in part by mitoKATP.